Common Aptitude Test for admission to DU, JNU other central universities likely from 2021-22

-

The Centre is planning to start a single entrance test called Common Aptitude Test for admissions to central universities from the 2021-2022 academic session. These include Delhi University, Jawaharlal Nehru University and Banaras Hindu University among others.

The government has reportedly planned the move with proposals forwarded by the National Education Policy, recently approved by the Union Cabinet.

A seven-member committee has been set up to recommend modalities and implementation of the Common Aptitude Test which will give students admission into central universities, India Today reported.

Higher Education secretary Amit Khare was quoted by The Times of India as saying that the computer-based common entrance exam, which will be conducted by the NTA, will be mandatory for admission to all central universities, and will be implemented from the 2021-22 session for the central universities.

Furthermore, UGC chairperson professor DP Singh said that the committee is expected to submit the recommendations within a month, while officials of the ministry of education revealed it would give an opportunity to universities to enroll aspirants with proficiency for a course and eliminate the need to appear for multiple entrance exams. While initially, the policy spoke of offering the exam a maximum of two times in a year, Khare said it would be conducted only once for the 2021-22 session.

The report also added that the seven-member committee will be headed by Professor RP Tiwari, vice chancellor of Central University of Punjab, Bathinda, while the other members include VCs of DU, as well Central University of South Bihar, Central University of Mizoram and Banaras Hindu University. The seven-member committee also includes the director general of NTA and joint secretary (central universities) of the ministry of education.

https://ift.tt/34JtVVA



from Firstpost India Latest News https://ift.tt/3mTAavY
FP Trending

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

Aditya L1 Mission: Spacecraft is nearing its final phase, says ISRO chief

-
Aditya L1 spacecraft is nearing its final phase, and manoeuvres to enter the L1 point are expected to be completed by January 7, 2024, according to ISRO Chairman S Somanath. “Aditya is on the way. I think it has reached almost its final phase,” the ISRO chief told PTI on the sidelines of an event organised at VSSC to commemorate the 60th year of the First Sounding Rocket Launch. Aditya L1, India’s first space-based mission to study the Sun, was successfully launched on September 2 from the Satish Dhawan Space Centre (SDSC) in Sriharikota. The spacecraft, after travelling about 1.5 million km from Earth over 125 days, is expected to be placed in a Halo orbit around the Lagrangian point L1, considered closest to the Sun. He said that the last preparations for the spacecraft’s entry into the L1 point are currently underway incrementally.”Possibly by January 7th, the final manoeuvres will be done for entering into the L1 point,” Somanath added. Among other tasks, it will capture and tr
Read more